Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+8.0%
5Y CAGR+15.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+8.0%/yr
vs +82.9%/yr prior
5Y CAGR
+15.2%/yr
Recent deceleration
Acceleration
-74.9pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.67M | -21.2% |
| 2024 | $87.11M | +46.7% |
| 2023 | $59.40M | +8.9% |
| 2022 | $54.55M | +33.2% |
| 2021 | $40.94M | +20.8% |
| 2020 | $33.89M | +300.6% |
| 2019 | $8.46M | +73.5% |
| 2018 | $4.88M | - |